Immune-based gene therapy candidates have the potential to prevail in oncology space but this uncharted territory will require new regulatory guidelines and restructuring of current treatment algorithms, according to a...
15 June 2018
11 June 2018
Gene therapies combine reduced treatment duration with a higher chance of success unlike conventional oncology treatments such as chemotherapy.
25 May 2018
Majority of global healthcare professionals in UK-based companies do not anticipate staff relocations post Brexit, according to a survey by GlobalData.
2 May 2018
Researchers from the University of Pennsylvania may have found the reason why some patients respond better to chimeric antigen receptor (CAR)-T cell therapy than others.
27 April 2018
Small biotech companies are currently predominant in the microbiome-targeted therapeutics area and larger pharmaceutical organisations are seeking their alliance to further drive development of the said drug pipeline for immunology,...
26 April 2018
Research led by the University of East Anglia (UEA) has found that long-term use of some anticholinergic medications such as antidepressants could lead to an increased risk of dementia.
25 April 2018
A study suggests that the availability of orphan drugs varies significantly between different countries in Europe.
23 April 2018
A report by Pharmaceutical Research and Manufacturers of America (PhRMA) has found that over 500 medicines for neurological disorders are currently in development.
6 April 2018
The market for age-related macular degeneration (AMD) drugs could grow at a compound annual growth rate of 8.9% and reach $11.5bn by 2026, according to a report.
2 March 2018
Late-stage chronic kidney disease (CKD) induced hyperparathyroidism (HPT), hyperphosphatemia (HP), and hyperkalemia (HK) therapeutics market is set to grow from $4.2bn in 2016 to $10.5bn in 2026 at a compound...